Press Release - Wednesday, April 06, 2005
Press Releases
No Data
GOV. BLAGOJEVICH ANNOUNCES SIGNIFICANT OPPORTUNITY RETURNS INVESTMENT IN PROMINENT PHARMACEUTICAL COMPANY FUELING MAJOR ECONOMIC EXPANSION AND BRINGING 500 NEW JOBS TO CHICAGOLAND AREA
CHICAGO - Gov. Rod Blagojevich today announced the awarding of more than $15 million in Opportunity Returns support to Takeda Pharmaceuticals North America, Inc. that will enable the company to relocate, expand and improve its North American headquarter operations in Deerfield, Ill. and bring 500 new jobs to the area. When all of the construction phases are complete, the 1.2 million square foot campus will accommodate up to five office buildings, including a conference/training facility, cafeteria, general store, fitness center and a 5,300 square foot remote delivery facility. The addition of Takeda's new campus also will serve as another vital component of an emerging biotech corridor taking shape in Northeast Illinois, strengthening the prominence of the industry in the state and attracting new investment to the area.
"The Chicagoland area has an economy that is healthy, diverse and vibrant. Our goal is to make the kinds of investments that will capitalize on those competitive strengths of this region and to help fuel more vigorous economic growth and job creation. In partnering with a leading pharmaceutical company like Takeda to build a state-of-the-art new campus in Deerfield, we're taking an important step toward achieving that goal while also fortifying the burgeoning biotech industry in our state," Gov. Blagojevich said.
"We very much appreciate the efforts of Gov. Blagojevich and his team and Village of Deerfield Mayor Steve Harris and his team as they worked side-by-side with us to ensure that Takeda would continue its rapid growth in the great state of Illinois," said Mark Booth, president of Takeda Pharmaceuticals North America, Inc. "We are excited to have a new headquarters campus that reflects Takeda's mission to improving healthcare and our commitment to being a leader in the pharmaceutical industry."
The Takeda property consists of 70.4 acres located at the northwest corner of the I-94 and Lake-Cook Road intersection in Deerfield. The property was purchased in December 2002. The company plans to complete the first phase of construction in 2006 with a 380,000 square-foot headquarters campus consisting of two office buildings. When all of the construction phases are complete, the campus will accommodate up to five office buildings. The landscape design and site improvements are intended to achieve the goal of "LEED"
certification for the project. The Leadership in Energy and Environmental Design (LEED™) Green Building Rating System is a national consensus-based, market-driven building rating system designed to accelerate the development and implementation of green building practices.
"Through key initiatives such as supporting this expansion at Takeda, we're driving home the message that this region is a great place for a business to grow, expand and prosper. Gov. Blagojevich continues to make the kinds of investments that are critical to fostering a more healthy, diverse and vibrant economy," State Senator Susan Garrett (D-Lake Forest) said.
"Gov. Blagojevich and I will continue doing everything we can to keep our economy moving forward. By partnering with Takeda on this exciting expansion, we are not only bringing 500 new, high-tech jobs to Deerfield but also a renewed sense of economic opportunity throughout the region," said State Rep. Karen May (D-Highland Park).
The Illinois Department of Commerce and Economic Opportunity (DCEO) will provide the support for Takeda. DCEO will make available Economic Development for a Growing Economy (EDGE)
tax credits based on job creation over a ten-year period, a Large Business Development Program (LBDP) grant, funding through its Employer Training Investment Fund to help train Takeda's workforce, and additional tax exemptions and credits for Takeda's status as a High Impact Business (HIB).
"Supporting Takeda's new headquarters in Deerfield is a tremendous investment that will pay immediate dividends by creating a significant number of new, high-tech jobs, increasing economic activity in the area and strengthening the company's operations. In doing so, we are also supporting an environmentally efficient approach to building design that gets the very most out of our limited resources. This is a win-win for the economic vitality of the region," DCEO Director Jack Lavin said.
"It's an honor to welcome Takeda as an annexed corporate member of the Deerfield community," said Village of Deerfield Mayor Steve Harris. "We're pleased that Takeda's leadership team saw the same things in Deerfield that makes this community so attractive to many other world-class companies, including a business-friendly environment, a convenient location and access to a highly-skilled workforce. We are also very thankful of the support from Gov. Blagojevich and DCEO."
Based in Lincolnshire, Ill., Takeda Pharmaceuticals North America, Inc. is a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, the largest pharmaceutical company in Japan. In the United States, Takeda currently markets oral diabetes and cholesterol lowering treatments, and through the Takeda Global Research & Development Center, Inc. the company has a robust pipeline with compounds in development for diabetes, sleep, cardiovascular disease and other conditions. Takeda is committed to striving toward better health for individuals and progress in medicine by developing superior pharmaceutical products. To learn more about the company and its products, visit www.tpna.com.
Press Releases
No Data